SCHEMBL8969367

SCHEMBL8969367

CN(CCCCBr)S(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.54
RAB9A P51151 3/20 0.51
HTT P42858 3/20 0.51
LMNA P02545 3/20 0.51
NPC1 O15118 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
GALR3 O60755 1/20 0.51
NR2F2 P24468 1/20 0.51
POLB P06746 2/20 0.46
VCAM1 P19320 2/20 0.45
SLC6A2 P23975 3/20 0.44
SLC6A4 P31645 3/20 0.44
KCNH2 Q12809 2/20 0.44
SLC6A3 Q01959 1/20 0.44
CYSLTR1 Q9Y271 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TPSAB1 Q15661 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14093582 0.85 PDE4D (0.56) PDE4DRAB9AHTTLMNANPC1
SCHEMBL14320162 0.85 SLC6A2 (0.58) PDE4DRAB9AHTTLMNANPC1
SCHEMBL14093583 0.82 PDE4D (0.59) PDE4DRAB9AHTTLMNANPC1
SCHEMBL6371454 0.81 PDE4D (0.57) PDE4DRAB9AHTTLMNANPC1
SCHEMBL9635340 0.81 PDE4D (0.57) PDE4DRAB9AHTTLMNANPC1
SCHEMBL5127182 0.81 GAA (0.66) PDE4DRAB9AHTTLMNANPC1
SCHEMBL8970747 0.76 KMT2A (0.52) LMNASMN1; SMN2POLBVCAM1MAPT
SCHEMBL14470052 0.75 POLB (0.67) PDE4DRAB9AHTTLMNANPC1
SCHEMBL29212110 0.74 NPC1 (0.61) PDE4DRAB9AHTTLMNANPC1
SCHEMBL29964126 0.74 NPC1 (0.61) PDE4DRAB9AHTTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5585392-A TREATING OR PREVENTING STROKES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5506246-A Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues BAYER AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
EP-0352613-B1 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1994-04-20 EP disclosed
US-5300523-A Binding serotonin receptors, treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
US-5137901-A For binding 5-HT 1 receptors; treating central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US disclosed
EP-0352613-A2 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1990-01-31 EP disclosed